$NKTR News Article - Nektar Therapeutics and Brist
Post# of 68
(Total Views: 462)
Posted On: 08/01/2019 12:00:42 PM
$NKTR News Article - Nektar Therapeutics and Bristol-Myers Squibb Announce U.S. FDA Breakthrough Therapy Designation for Bempegaldesleukin (NKTR-214) in Combination with Opdivo (nivolumab) for the Treatment of Patients with Untreated Advanced Melanoma https://marketwirenews.com/news-releases/nekt...08961.html
(0)
(0)Nektar Therapeutics (NKTR) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼